Actively Recruiting
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
Led by London School of Economics and Political Science · Updated on 2025-05-30
3000
Participants Needed
1
Research Sites
3 weeks
Total Duration
On this page
Sponsors
L
London School of Economics and Political Science
Lead Sponsor
H
Harvard Medical School / Harvard Pilgrim Health Care Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
CONDITIONS
Official Title
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age and older
- Adults fluent in English
- Adults residing in the United States
You will not qualify if you...
- Participants who do not meet each of the 3 inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Harvard Medical School and Harvard Pilgrim Health Care Institute
Boston, Massachusetts, United States, 02139
Actively Recruiting
Research Team
A
Avi Cherla
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here